SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950134-04-018033
Filing Date
2004-11-22
Accepted
2004-11-22 16:46:25
Documents
4
Period of Report
2004-11-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f03577e8vk.htm 8-K 11512
2 EXHIBIT 10.52 f03577exv10w52.htm EX-10.52 74969
3 EXHIBIT 99.1 f03577exv99w1.htm EX-99.1 10822
4 GRAPHIC f03577f0357700.gif GRAPHIC 4096
  Complete submission text file 0000950134-04-018033.txt   103460
Mailing Address 25861 INDUSTRIAL BLVD HAYWARD CA 94545
Business Address 25861 INDUSTRIAL BLVD HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Filer) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22570 | Film No.: 041161233
SIC: 2833 Medicinal Chemicals & Botanical Products